Annual FCF
-$18.11 M
-$2.25 M-14.16%
01 December 2023
Summary:
TransCode Therapeutics annual free cash flow is currently -$18.11 million, with the most recent change of -$2.25 million (-14.16%) on 01 December 2023. During the last 3 years, it has fallen by -$12.59 million (-227.98%). RNAZ annual FCF is now -3573.45% below its all-time high of -$493.00 thousand, reached on 31 December 2020.RNAZ Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$3.93 M
-$1.58 M-67.45%
01 September 2024
Summary:
TransCode Therapeutics quarterly free cash flow is currently -$3.93 million, with the most recent change of -$1.58 million (-67.45%) on 01 September 2024. Over the past year, it has increased by +$1.74 million (+30.69%). RNAZ quarterly FCF is now -21587.85% below its all-time high of -$18.10 thousand, reached on 01 March 2020.RNAZ Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$15.87 M
-$415.10 K-2.69%
01 September 2024
Summary:
TransCode Therapeutics TTM free cash flow is currently -$15.87 million, with the most recent change of -$415.10 thousand (-2.69%) on 01 September 2024. Over the past year, it has increased by +$2.24 million (+12.35%). RNAZ TTM FCF is now -87603.87% below its all-time high of -$18.10 thousand, reached on 01 March 2020.RNAZ TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAZ Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +30.7% | +12.3% |
| 3 y3 years | -228.0% | -132.8% | -187.5% |
| 5 y5 years | -3461.5% | - | - |
RNAZ Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -228.0% | at low | -132.8% | +30.7% | -187.5% | +12.3% |
| 5 y | 5 years | -3573.4% | at low | <-9999.0% | +30.7% | <-9999.0% | +12.3% |
| alltime | all time | -3573.4% | at low | <-9999.0% | +30.7% | <-9999.0% | +12.3% |
TransCode Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.93 M(+67.4%) | -$15.87 M(+2.7%) |
| June 2024 | - | -$2.34 M(-40.5%) | -$15.46 M(-11.8%) |
| Mar 2024 | - | -$3.94 M(-30.4%) | -$17.52 M(-3.2%) |
| Dec 2023 | -$18.11 M(+14.2%) | -$5.66 M(+61.3%) | -$18.11 M(+9.8%) |
| Sept 2023 | - | -$3.51 M(-20.4%) | -$16.49 M(-5.2%) |
| June 2023 | - | -$4.41 M(-2.6%) | -$17.41 M(+6.1%) |
| Mar 2023 | - | -$4.53 M(+11.8%) | -$16.41 M(+3.4%) |
| Dec 2022 | -$15.86 M | -$4.05 M(-8.5%) | -$15.86 M(+17.5%) |
| Sept 2022 | - | -$4.42 M(+29.5%) | -$13.50 M(+10.5%) |
| June 2022 | - | -$3.41 M(-14.2%) | -$12.22 M(+37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.98 M(+135.9%) | -$8.90 M(+61.2%) |
| Dec 2021 | -$5.52 M(+1020.0%) | -$1.69 M(-46.3%) | -$5.52 M(+35.0%) |
| Sept 2021 | - | -$3.14 M(+3097.0%) | -$4.09 M(+278.1%) |
| June 2021 | - | -$98.20 K(-83.6%) | -$1.08 M(+0.9%) |
| Mar 2021 | - | -$597.50 K(+133.9%) | -$1.07 M(+117.5%) |
| Dec 2020 | -$493.00 K(-3.0%) | - | - |
| Dec 2020 | - | -$255.50 K(+95.3%) | -$492.90 K(+107.6%) |
| Sept 2020 | - | -$130.80 K(+47.8%) | -$237.40 K(+122.7%) |
| June 2020 | - | -$88.50 K(+389.0%) | -$106.60 K(+489.0%) |
| Mar 2020 | - | -$18.10 K | -$18.10 K |
| Dec 2019 | -$508.50 K | - | - |
FAQ
- What is TransCode Therapeutics annual free cash flow?
- What is the all time high annual FCF for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly FCF year-on-year change?
- What is TransCode Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for TransCode Therapeutics?
- What is TransCode Therapeutics TTM FCF year-on-year change?
What is TransCode Therapeutics annual free cash flow?
The current annual FCF of RNAZ is -$18.11 M
What is the all time high annual FCF for TransCode Therapeutics?
TransCode Therapeutics all-time high annual free cash flow is -$493.00 K
What is TransCode Therapeutics quarterly free cash flow?
The current quarterly FCF of RNAZ is -$3.93 M
What is the all time high quarterly FCF for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly free cash flow is -$18.10 K
What is TransCode Therapeutics quarterly FCF year-on-year change?
Over the past year, RNAZ quarterly free cash flow has changed by +$1.74 M (+30.69%)
What is TransCode Therapeutics TTM free cash flow?
The current TTM FCF of RNAZ is -$15.87 M
What is the all time high TTM FCF for TransCode Therapeutics?
TransCode Therapeutics all-time high TTM free cash flow is -$18.10 K
What is TransCode Therapeutics TTM FCF year-on-year change?
Over the past year, RNAZ TTM free cash flow has changed by +$2.24 M (+12.35%)